BMRN
$58.51+0.90%
as of close, Nov 17, 2026
☾ AH $58.51 +0.90%
BioMarin Pharmaceutical Inc.Stock · HealthcareNasdaq Composite · 0.03% of ONEQRussell 1000 · 0.02% of IWBUS Stock Market · 0.02% of VTIRussell 3000 · 0.01% of IWV
Head-to-head:Compare with INCY or any ticker →
BioMarin Pharmaceutical Inc. total returns by year (including dividends)
As of market close, Nov 17, 2026
Every year since 1999#
Data provided bySource: Twelve DataCalendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start | End | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $59.43 | $58.51 | 0.0% | -1.5% | |
| 2025 | $65.73 | $59.43 | 0.0% | -9.6% | |
| 2024 | $96.42 | $65.73 | 0.0% | -31.8% | |
| 2023 | $103.49 | $96.42 | 0.0% | -6.8% | |
| 2022 | $88.35 | $103.49 | 0.0% | +17.1% | |
| 2021 | $87.69 | $88.35 | 0.0% | +0.8% | |
| 2020 | $84.55 | $87.69 | 0.0% | +3.7% | |
| 2019 | $85.15 | $84.55 | 0.0% | -0.7% | |
| 2018 | $89.17 | $85.15 | 0.0% | -4.5% | |
| 2017 | $82.84 | $89.17 | 0.0% | +7.6% | |
| 2016 | $104.76 | $82.84 | 0.0% | -20.9% | |
| 2015 | $90.40 | $104.76 | 0.0% | +15.9% | |
| 2014 | $70.35 | $90.40 | 0.0% | +28.5% | |
| 2013 | $49.20 | $70.35 | 0.0% | +43.0% | |
| 2012 | $34.38 | $49.20 | 0.0% | +43.1% | |
| 2011 | $26.93 | $34.38 | 0.0% | +27.7% | |
| 2010 | $18.81 | $26.93 | 0.0% | +43.2% | |
| 2009 | $17.80 | $18.81 | 0.0% | +5.7% | |
| 2008 | $35.40 | $17.80 | 0.0% | -49.7% | |
| 2007 | $16.39 | $35.40 | 0.0% | +116.0% | |
| 2006 | $10.78 | $16.39 | 0.0% | +52.0% | |
| 2005 | $6.39 | $10.78 | 0.0% | +68.7% | |
| 2004 | $7.76 | $6.39 | 0.0% | -17.7% | |
| 2003 | $7.05 | $7.76 | 0.0% | +10.1% | |
| 2002 | $13.44 | $7.05 | 0.0% | -47.5% | |
| 2001 | $9.69 | $13.44 | 0.0% | +38.7% | |
| 2000 | $11.75 | $9.69 | 0.0% | -17.6% | |
| 1999since Jul 26 | $13.00 | $11.75 | 0.0% | -9.6% |
- Annualized
- +6.0%
- 2000–2026
- Average year
- +12.1%
- 26 full years
- Best year
- +116.0%
- 2007
- Worst year
- -49.7%
- 2008
- Positive years
- 16/26
- 62% up
Annualized (CAGR)
+6.0%
2000–2026
Average year
+12.1%
26 full years
Best year
+116.0%
2007
Worst year
-49.7%
2008
Positive years
16/26
62% up
Total return by period#
Annual
−150%−100%−50%0%50%100%150%
1999, since Jul 26-9.6%'99
2000-18%
2001+39%'01
2002-48%
2003+10%'03
2004-18%
2005+69%'05
2006+52%
2007+116%'07
2008-50%
2009+5.7%'09
2010+43%
2011+28%'11
2012+43%
2013+43%'13
2014+29%
2015+16%'15
2016-21%
2017+7.6%'17
2018-4.5%
2019-0.7%'19
2020+3.7%
2021+0.75%'21
2022+17%
2023-6.8%'23
2024-32%
2025-9.6%'25
2026-1.5%
Methodology#
Total returns, dividends reinvested, measured on BMRN. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is BioMarin Pharmaceutical Inc.'s average annual return?
- Since 2000, BioMarin Pharmaceutical Inc. (BMRN) has returned about 6.0% a year (the compound annual growth rate) and an average calendar-year return of 12.1%.
- What were BioMarin Pharmaceutical Inc.'s best and worst years?
- Over 2000–2026, the best year was 2007 (+116.0%) and the worst was 2008 (-49.7%).
- How often is BioMarin Pharmaceutical Inc. up in a year?
- 16 of the 26 full years since 2000 were positive — about 62% of the time.
More on BioMarin Pharmaceutical Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100
Head-to-head:Compare with INCY or any ticker →
